Inactivation of DNA-polymerase associated with hepatitis B virus
β Scribed by Nrapendra Nath; Chyang T. Fang; Roger Y. Dodd
- Publisher
- John Wiley and Sons
- Year
- 1982
- Tongue
- English
- Weight
- 662 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
The effects of heat, sodium hypochlorite, diethyl ether, and ethyl alcohol on the activity of DNA polymerase (DNAβP) associated with hepatitis B virsus (HBV) in serum were evaluated. The response of DNAβP to heating at 60Β°C for 15, 30, 45, 60, 90, 120, 180, and 240 minutes was studied and the data suggested that there may be two types of DNAβP. The majority of DNAβP was type βaβ, and it showed a one log redution (D60) at 60Β°C in 36 minutes, while the remaining activity was type βbβ that showed a one log reduction (D60) in 340 minutes. Treatment of DNAβP with sodium hypochlorite at concentrations of 250 and 500 parts per million (ppm) of available chlorine resulted in a 20 to 25% reduction in DNAβP activity within one minute. Complete loss in detectable DNAβP activity occurred within one minute when available Clβ was 2500 ppm or greater. Various concentrations of ethyl alcohol (ranging from 10 to 70%) caused gradually increasing inactivation of DNAβP activity in ten minutes at 4Β°C. Ninety percent inactivation occurred with 60% alcohol. Overnight treatment of DNAβPβreactive material with diethyl ether at 4Β°C led to loss of detectable activity. A reduction in the titer of HBsAg was found following treatment with alcohol or ether. The possible use of DNAβP assay as an indicator of the rate of inactivation of HBV is proposed.
π SIMILAR VOLUMES
Human hepatitis B virus (HBV) DNA polymerase activity was inhibited by pyridoxal 5'-phosphate (PLP) specifically and noncompetitively with respect to deoxythymidine triphosphate (dTTP). NaBH, reduction of PLP-HBV core proteins resulted in the complete inactivation of HBV DNA polymerase, and PLP modi
In order to determine the relationship between hepatitis B virus (HBV) infection of human white blood cells and different forms of HBV-associated liver diseases, we tested for HBV DNA in the sera and leukocytes of 11 healthy individuals without any serological markers of HBV infection and 91 patient
Several mutations (V521L, P525L, L528M, T532S, and V555I) in the gene for hepatitis B virus (HBV) polymerase have been identified in HBV isolated from patients that displayed break-through viremia during famciclovir treatment. To determine whether these mutations cause phenotypic resistance to famci
Defective hepatitis B virus DNA (dDNA) is reverse-transcribed from spliced hepatitis B virus (HBV) pregenomic messenger RNA (pgRNA) and has been identified in patients with chronic HBV (CH-B). The major 2.2-kb spliced pgRNA encodes a novel HBV gene product, the hepatitis B splice protein (HBSP) via